| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 25 May 2026 | 18 May 2026 |
| Audited Results & Employees Stock Option Plan Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve and take on record the Audited Standalone and Consolidated Financial Results/Statements of the Company for the quarter and year ended March 31, 2026. Outcome of Board Meeting held on May 25, 2026 (As Per BSE Announcement Dated on: 25/05/2026) | ||
| Board Meeting | 12 Feb 2026 | 3 Feb 2026 |
| Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve and take on record the Unaudited Standalone and Consolidated Financial Results (along with Limited Review) of the Company for the quarter and nine months ended December 31 2025 Outcome of the Board meeting held on February 12, 2026 Submission of unaudited financial results for the quarter and nine months ended December 31, 2025 (As Per BSE Announcement Dated on 12.02.2026) | ||
| Board Meeting | 12 Nov 2025 | 29 Oct 2025 |
| Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter alia to consider and approve Financial results for the period ended September 30 2025 Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Acquisition Outcome of Board Meeting dated November 12, 2025 (As Per BSE Announcement Dated on: 12/11/2025) | ||
| Board Meeting | 29 Sep 2025 | 29 Sep 2025 |
| Outcome of Board meeting dated September 29, 2025 | ||
| Board Meeting | 8 Aug 2025 | 25 Jul 2025 |
| Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 inter alia to consider and approve and take on record the standalone and consolidated unaudited financial results of the Company for the Quarter ended June 30 2025 Outcome of Board Meeting dated August 08, 2025 Submission of Unaudited Financial Results for the quarter ended June 30, 2025 (As Per BSE Announcement Dated on:08.08.2025) | ||
| Board Meeting | 18 Jun 2025 | 18 Jun 2025 |
| Outcome of Board Meeting held on June 18, 2025 | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
